Search research articles
Contact Us
Filters
Showing results (741-750 of 760) with videos related to
Page
of 76
Sort By:
Human Mutation
|
April 1, 2020
TAR syndrome: Clinical and molecular characterization of a cohort of 26 patients and description of novel noncoding variants of RBM8A
Simon Boussion, Fabienne Escande, Anne-Sophie Jourdain, et al.
The Journal of Molecular Diagnostics : JMD
|
November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms
Michèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 10, 2020
Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups
Christian Carrie, Virginie Kieffer, Dominique Figarella-Branger, et al.
Nature Communications
|
October 13, 2022
INTS13 variants causing a recessive developmental ciliopathy disrupt assembly of the Integrator complex
Lauren G Mascibroda, Mohammad Shboul, Nathan D Elrod, et al.
Nature Communications
|
September 12, 2020
Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology
Sahar Elouej, Karim Harhouri, Morgane Le Mao, et al.
Nature Communications
|
October 20, 2020
Author Correction: Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology
Sahar Elouej, Karim Harhouri, Morgane Le Mao, et al.
Cell
|
March 15, 2020
Comprehensive In Vivo Interrogation Reveals Phenotypic Impact of Human Enhancer Variants
Evgeny Z Kvon, Yiwen Zhu, Guy Kelman, et al.
The Lancet Regional Health. Europe
|
November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Lancet (London, England)
|
January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
Lancet (London, England)
|
April 11, 2022
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Karim Fizazi, Stéphanie Foulon, Joan Carles, et al.
Page
of 76
Search research articles
Search
Showing results (741-750 of 760) with videos related to
Sort By:
Page
of 76
Human Mutation
|
April 1, 2020
TAR syndrome: Clinical and molecular characterization of a cohort of 26 patients and description of novel noncoding variants of RBM8A
Simon Boussion, Fabienne Escande, Anne-Sophie Jourdain, et al.
The Journal of Molecular Diagnostics : JMD
|
November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms
Michèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 10, 2020
Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups
Christian Carrie, Virginie Kieffer, Dominique Figarella-Branger, et al.
Nature Communications
|
October 13, 2022
INTS13 variants causing a recessive developmental ciliopathy disrupt assembly of the Integrator complex
Lauren G Mascibroda, Mohammad Shboul, Nathan D Elrod, et al.
Nature Communications
|
September 12, 2020
Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology
Sahar Elouej, Karim Harhouri, Morgane Le Mao, et al.
Nature Communications
|
October 20, 2020
Author Correction: Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology
Sahar Elouej, Karim Harhouri, Morgane Le Mao, et al.
Cell
|
March 15, 2020
Comprehensive In Vivo Interrogation Reveals Phenotypic Impact of Human Enhancer Variants
Evgeny Z Kvon, Yiwen Zhu, Guy Kelman, et al.
The Lancet Regional Health. Europe
|
November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis
Célia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Lancet (London, England)
|
January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
Lancet (London, England)
|
April 11, 2022
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Karim Fizazi, Stéphanie Foulon, Joan Carles, et al.
Page
of 76